Skip to main content
Premium Trial:

Request an Annual Quote

Natera Sues Progenity, Alleging Noninvasive Prenatal Test Infringes Patents

NEW YORK – Natera has sued Progenity, alleging that the molecular diagnostics firm's noninvasive prenatal Innatal test infringes six of its patents.

The suit comes shortly after Progenity filed for an initial public offering in which it is seeking to raise up to $122.6 million.

In its complaint, filed on Wednesday with the US District Court for the Western District of Texas, Waco Division, Natera claims that the use and sale of Progenity's Innatal Prenatal Screen test infringes six of its patents: US Patents 9,228,234 and 10,522,242, both titled "Methods for noninvasive prenatal ploidy calling"; US Patents 9,424,392, 10,227,652, and 10,240,202, all titled "System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals;" and US Patent 10,266,893, titled "System and method for cleaning noisy genetic data and determining chromosome copy number."

Natera is seeking injunctive relief, monetary damages, court expenses, and a jury trial.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.